Novo Nordisk's new GLP-1 pill highlights the risk that Eli Lilly faces, as investors reward it for being at the forefront of ...
11don MSN
3 Drug Stocks to Buy at a Discount
The GLP-1 fight just entered a new round, and it highlights why these three out-of-favor drug makers are worth a deep dive.
SciSparc Ltd. (NASDAQ: SPRC) stock is surging on Thursday, with a session volume of 58.21 million compared to the average volume of 2.49 million as per data from Benzinga Pro. SPRC stock is racing ...
In a recent social media post, Peter Ray, senior director of medicinal chemistry at Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), drew attention to a new article in WIRED from Veronique Greenwood ...
Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...
Pfizer has a substantial 6.6% dividend yield but a payout ratio exceeding 100%. Eli Lilly has a payout ratio of roughly 30%, but its dividend yield is a tiny 0.6%. Long-term income investors can find ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback